Violation Tracker Individual Record

Company: 
Ranbaxy
Current Parent Company: 
Sun Pharmaceuticals
Penalty: 
$266,729,715
Year: 
2013
Date: 
May 13, 2013
Offense Group: 
safety-related offenses
Primary Offense: 
drug or medical equipment safety violation
Violation Description: 

Ranbaxy paid $266 million to resolve multistate litigation alleging that it sold generic drugs that lacked necessary active ingredients due to poor quality control standards to customers including state Medicaid programs. This was part of a larger $500 million civil and criminal settlement that involved the federal government; see the Violation Tracker entry at https://violationtracker.goodjobsfirst.org/violation-tracker/-ranbaxy-us...

Level of Government: 
state
Action Type: 
agency action
Agency: 
Multistate Attorneys General Case
Civil or Criminal Case: 
civil
HQ Country of Parent: 
India
Ownership Structure of Parent: 
publicly traded
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.